Prostaglandin D2 receptor

Description:

Description
  • Accession: Q13258
  • Swissprot: PD2R_HUMAN
  • Organism: Homo sapiens
  • Gene: PTGDR
  • Target class: GPCR

Drug Relations:

laropiprant
a potent orally active human prostaglandin D(2) receptor 1 antagonist Bioactivity details MOA
alprostadil
A potent vasodilator agent that increases peripheral blood flow. Bioactivity details MOA
cicaprost
Bioactivity details MOA
dinoprost
A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. Bioactivity details MOA
dinoprostone
The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. Bioactivity details MOA
iloprost
An eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation. Bioactivity details MOA
mezlocillin
Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections. Bioactivity details MOA
ramatroban
thromboxane A2 receptor antagonist; BAY u 3405 & 3406 are enantiomers of each other Bioactivity details MOA
treprostinil
Bioactivity details MOA